granted
on 14 Nov 2023
Last Applicant/ Owned by
1140 O'Brien Drive
Menlo Park
CA
94025
Serial Number
97354266 filed on 08th Apr 2022
Registration Number
N/A
Correspondent Address
Aaron D. Hendelman
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"THERAPEUTICS"
Scientific and biotechnology research and analysis in the fields of cell and gene therapy and drug delivery; research and development of medicines and drug delivery platforms for the treatment of diseases; providing scientific research and medical research information in the fields of genetic medicine and drug delivery; medical and scientific research in the field of pharmaceuticals; pharmaceuticaRead More
Providing medical information in the fields of genetic medicine and drug delivery
Scientific and biotechnology research and analysis in the fields of cell and gene therapy and drug delivery; research and development of medicines and drug delivery platforms for the treatment of diseases; providing scientific research and medical research information in the fields of genetic medicine and drug delivery; medical and scientific research in the field of pharmaceuticals; pharmaceutical research and products development of pharmaceuticals for the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer
Providing online non-downloadable articles, books, magazines, journals, and scientific texts in the fields of genetic medicine and drug delivery
Downloadable electronic publications in the nature of articles, books, magazines, journals, and scientific texts in the fields of genetic medicine and drug delivery
Medicines for the modification of genes and treatment of diseases, for use in the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; cell and gene therapy biological preparations and pharmaceutical preparations with protein expression, all for the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; drug carriers for medical use, namely, delivery agents in the form of non-viral lipid nanoparticles for delivering drugs to human organs that facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment and prevention of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer
No 97354266
No Service Mark
No 58530-TM1004
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 16th Nov 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 14th Nov 2023 | SOU TEAS EXTENSION RECEIVED |
| 14th Nov 2023 | SOU EXTENSION 1 FILED |
| 14th Nov 2023 | SOU EXTENSION 1 GRANTED |
| 23rd May 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 28th Mar 2023 | PUBLISHED FOR OPPOSITION |
| 28th Mar 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 08th Mar 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 18th Feb 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 04th Feb 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
